Disorganized vascular structures in sporadic venous malformations: A possible correlation with balancing effect between Tie2 and TGF-2

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Chen, Gang ^a,b   Ren, Jian Gang ^a   Zhang, Wei ^a   Sun, Yan Fang ^a,b   Wang, Feng Qin ^a   Li, Rui Fang ^a   Zhang, Jian ^a   Zhao, Yi Fang ^a,b  

^a WUHAN UNIVERSITY   (China)

^b Wuhan University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; CELL ADHESION MOLECULE; TRANSFORMING GROWTH FACTOR BETA;

ABNORMALITIES; BIOLOGICAL MODEL; CELL CULTURE; CONGENITAL BLOOD VESSEL MALFORMATION; FEMALE; HUMAN; MALE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; STATISTICS; VEIN;

CELL ADHESION MOLECULES; CELLS, CULTURED; FEMALE; HUMANS; MALE; MODELS, CARDIOVASCULAR; RECEPTOR, TIE-2; SIGNAL TRANSDUCTION; STATISTICS AS TOPIC; TRANSFORMING GROWTH FACTOR BETA; VASCULAR MALFORMATIONS; VEINS;

EID: 84903301099     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05457     Document Type: Article

References (30)

1. Richter, G. T. & Friedman, A. B. Hemangiomas and vascular malformations: current theory and management. Int J Pediatr 2012, 645678 (2012).
2. Tucci, F. M. et al. Head and neck vascular anomalies in children. Int J Pediatr Otorhinolaryngol 73 Suppl 1, S71-6 (2009).
3. Wang, Y., Qi, F. & Gu, J. Endothelial cell culture of intramuscular venous malformation and its invasive behavior related to matrix metalloproteinase-9. Plast Reconstr Surg 123, 1419-30 (2009).
4. Legiehn, G. M. & Heran, M. K. Venous malformations: classification, development, diagnosis, and interventional radiologic management. Radiol Clin North Am 46, 545-97, (2008).
5. Cahill, A. M. & Nijs, E. L. Pediatric vascular malformations: pathophysiology, diagnosis, and the role of interventional radiology. Cardiovasc Intervent Radiol 34, 691-704 (2011).
6. Gupta, A.& Kozakewich, H.Histopathology of vascular anomalies. Clin Plast Surg 38, 31-44 (2011).
7. Hristov, N., Atanasov, Z., Zafirovski, G. & Mitrev, Z. Intramuscular cavernous hemangioma in the left soleus muscle: successful surgical treatment. Interact Cardiovasc Thorac Surg 13, 521-2 (2011).
8. Dhupar, V., Yadav, S., Dhupar, A. & Akkara, F. Cavernous hemangioma-uncommon presentation in zygomatic bone. J Craniofac Surg 23, 607-9 (2012).
9. Ramina, K., Ebner, F. H., Ernemann, U. & Tatagiba, M. Surgery of Cavernous Hemangioma of the Optic Nerve: Case Report and Review. J Neurol Surg A Cent Eur Neurosurg 74, 265-70 (2013).
10. Sanghvi, D., Munshi, M., Kulkarni, B. & Kumar, A. Dorsal spinal epidural cavernous hemangioma. J Craniovertebr Junction Spine 1, 122-5 (2010).
11. Buckmiller, L. M., Richter, G. T. & Suen, J. Y. Diagnosis and management of hemangiomas and vascular malformations of the head and neck. Oral Dis 16, 405-18 (2010).
12. Morris, P. N. et al. Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations. J Mol Med (Berl) 83, 58-63 (2005). (Pubitemid 40169497)
13. Valenzuela, D. M. et al. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci USA 96, 1904-9 (1999). (Pubitemid 29117840)
14. Thomas, M. & Augustin, H. G. The role of the Angiopoietins in vascular morphogenesis. Angiogenesis 12, 125-37 (2009).
15. Wouters, V. et al. Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur JHum Genet 18, 414-20 (2010).
16. Vikkula, M. et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87, 1181-90 (1996). (Pubitemid 27010102)
17. Limaye, N. et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet 41, 118-24 (2009).
18. Blaschuk, O. W. & Devemy, E. Cadherins as novel targets for anti-cancer therapy. Eur J Pharmacol 625, 195-8 (2009).
19. Derycke, L. et al. Soluble N-cadherin fragment promotes angiogenesis. Clin Exp Metastasis 23, 187-201 (2006). (Pubitemid 44673808)
20. Huang, Y. H. et al. STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production. Angiogenesis 16, 207-22 (2013).
21. Gaengel, K., Genové, G., Armulik, A. & Betsholtz, C. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 29, 630-8 (2009).
22. Dickson, M. C. et al.Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121, 1845-54 (1995).
23. Cao, R. et al. Angiogenic synergism, vascular stability and improvement of hindlimb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9, 604-13 (2003). (Pubitemid 36597108)
24. Brouillard, P. & Vikkula, M. Genetic causes of vascular malformations. HumMol Genet 16 Spec No. 2, R140-9 (2007).
25. Kontos, C.D. et al. Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol 18, 4131-40 (1998). (Pubitemid 28287936)
26. Chen, G. et al. Hypoxia-induced autophagy in endothelial cells: a double-edged sword in the progression of infantile haemangioma. Cardiovasc Res 98, 437-48 (2013).
27. Sun, Z. J. et al. LMO2 promotes angiogenesis probably by up-regulation of bFGF in endothelial cells: an implication of its pathophysiological role in infantile haemangioma. Histopathology 57, 622-32 (2010).
28. Zou, H. X., Jia, J., Zhang, W. F., Sun, Z. J. & Zhao, Y. F. Propranolol inhibits endothelial progenitor cell homing: a possible treatment mechanism of infantile hemangioma. Cardiovasc Pathol 22, 203-10 (2013).
29. Chen, G. et al. Mammalian target of rapamycin regulates isoliquiritigenininduced autophagic and apoptotic cell death in adenoid cystic carcinoma cells. Apoptosis 17, 90-101 (2012).
30. Jia, J. et al. Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma. PLoS One 7, e51549 (2012).